ARCHIVES

Bevacizumab And Irinotecan May Increase Survival Of GBM

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

Schwetz Replaces Koski As HHS Human Research Protections Director

February 7, 2003

In Brief: Leukemia Society, Glaxo Award Fellowship; Penn Leads CLF; Wight Heads Charity

September 10, 1999

Hammer to Produce US-USSR “Cancer Summit” March 29

March 25, 1988

Urologists support Approval Of Il-2 for Kidney Cancer

February 1, 1991

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

September 28, 2007

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

September 30, 2011